Metraipolis › archive › dc_f0f672fff102

Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology — Europe PMC PMID:40952332

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/40952332
DOI
10.1111/ddg.15796
License (as archived)
solo-consultazione
Archived
2026-11-10T05:54:01.169Z
SHA-256 of the archived text
fb7cdfe8e321eb0002bfb661f06d028d9b6894f011d2ec289a6f82e3ede6532c
Stable URL of this page
https://metraipolis.com/documento/dc_f0f672fff102

How to cite

Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology — Europe PMC PMID:40952332 — Europe PMC (en), https://europepmc.org/article/MED/40952332 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f0f672fff102 (Metraipolis archive dc_f0f672fff102, sha256 fb7cdfe8e321eb0002bfb661f06d028d9b6894f011d2ec289a6f82e3ede6532c)
BibTeX
@misc{dcf0f672fff102,
  title = {Adverse effects of Janus kinase inhibitors with relevance for daily practice in dermatology — Europe PMC PMID:40952332},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40952332},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f0f672fff102; sha256 fb7cdfe8e321eb0002bfb661f06d028d9b6894f011d2ec289a6f82e3ede6532c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40952332. Agents can read the archived copy with the MCP tool read_document.